Jan. 12, 2024
by Dana Sokolova
Biopharma insight
In 2023, the venture capital (VC) landscape witnessed significant activity, providing crucial support to the biotech sector amidst a volatile …
Jan. 7, 2024
by Andrii Buvailo
News
Isomorphic Labs, a digital biology company specializing in AI applications, has entered into two distinct research collaborations with Eli Lilly …
Jan. 3, 2024
by Dana Sokolova
News
Executives from the French AI drug discovery company Owkin have embarked on a new venture, launching Bioptimus, a startup dedicated …
Nov. 6, 2019
by Andrii Buvailo
Interview
Variational AI is a newly formed artificial intelligence (AI)-driven molecule discovery & drug design startup out of Vancouver, British Columbia, …
April 1, 2023
by Andrii Buvailo
Biopharma insight
The monoclonal antibodies (mAbs) market has seen impressive growth in recent years, with the top-selling drugs increasingly being mAbs. The …
Jan. 15, 2024
by Roman Kasianov
News
Mesenbio, a pioneering biotechnology firm emerging from the University of York, has recently secured a significant £1.4 million investment. This …
Jan. 11, 2024
by Illia Petrov
News
Xcell Biosciences, Inc., a notable company in the field of cell and gene therapy applications, has recently unveiled a strategic …
Aug. 2, 2022
by Andrii Buvailo
Biopharma insight
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep …
Nov. 29, 2020
by Andrii Buvailo
Biopharma insight
Table of Contents: Introduction The abundance of venture capital, major funding rounds New AI-driven biotech startups founded in 2020 Notable …
March 4, 2020
by Irina Bilous
Biopharma insight
Alongside the topic of gene editing technologies that keeps making headlines these days, there is also a wave of breakthroughs …
April 12, 2024
by Andrii Buvailo, PhD
Interview
My interview with Mirit Eldor, Managing Director, Life Sciences Solutions, at Elsevier, as we discuss Elsevier's recent collaboration with gen …
Jan. 4, 2024
by Andrii Buvailo
News
In a new development in oncology, the Menarini Group and Insilico Medicine have announced an exclusive global licensing agreement. This …